BBC News reported on Wednesday that South Korea has approved the import of remdesivir, a drug that appears to shorten recovery time for people with COVID-19.
Reportedly, remdesivir cuts the duration of symptoms from 15 days down to 11 in clinical trials at hospitals around the world.
The drug is already approved for treatment of COVID-19 in the US, Japan and India.
According to the BBC, remdesivir is an anti-viral medicine that has been used against Ebola. Other drugs being investigated include medication used for malaria and HIV.
Kromek collaborates on next-gen CT detector technology
Gilead Sciences initiates Phase 2 trial in Europe to evaluate lenacapavir for HIV prevention
European Commission grants authorisation to ViiV Healthcare's Apretude for prevention of HIV
Celanese to supply VitalDose drug delivery platform for Population Council's MPT Intravaginal Ring
Henry Schein introduces equipment repair subscription - Henry Schein Thrive Service Plus
Seres Therapeutics provides business updates and reports Q2 2023 financial results